Tvardi Therapeutics (TVRD) Q2 2025 Earnings

13MayConfirmed
Q1 2025
Q2 2025
-7.08
-4.92
-2.75
-0.59

Details

Expected EPS
-0.585
Actual EPS
-3.22
Surprise EPS
-2.64
Surprise Percent
+450.43%

Description

Tvardi Therapeutics (TVRD) has reported earnings of -3.22 per share for Q2 2025.

0 Comments

Share your thoughts